Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service SI joint fusion cases in Minnesota: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 16% on average (37 state-years, 2020–2024): small markets swing, so treat it as rough.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 1 | 70 | 49% |
| 2020 | 1 | 66 | 52% |
| 2021 | 4 | 82 | 56% |
| 2022 | 5 | 112 | 59% |
| 2023 | 4 | 180 | 62% |
| 2024 | 3 | 178 | 64% |
| 2025 from claims | – | 192 155–226 | 65% |
| 2026 forecast | – | 231 181–291 | 61% |
| 2027 forecast | – | 257 191–340 | 61% |
| 2028 forecast | – | 285 202–394 | 61% |
| 2029 forecast | – | 317 215–454 | 60% |
| 2030 forecast | – | 351 230–522 | 60% |
Minimally invasive and open sacroiliac joint fusion. Professional codes (what the surgeon bills): CPT 27279, 27280, 0775T, 27278.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 100% of the cases CMS names in Minnesota; 2 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 30% inpatient hospital, 28% hospital outpatient, 41% surgery center.
CMS rule changes ahead
From CMS’s OPPS/ASC final rules; the move measured on CMS’s claim summary, nationally, code by code. Medicare only, and not in the projected bars.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Ohio | 7 | 367+22%/yr | +22%/yr | 0.3 | 11% | 610 in 2030+8.7%/yr |
| Indiana | 3 | 192+9%/yr | +9%/yr | 0.2 | 27% | 430 in 2030+14%/yr |
| Missouri | 3 | 175−4%/yr | −4%/yr | 0.3 | 40% | 760 in 2030+28%/yr |
| Illinois | 2 | 171+8.4%/yr | +8.4%/yr | 0.1 | 0% | 380 in 2030+14%/yr |
| Kansas | 5 | 149+26%/yr | +26%/yr | 0.3 | 50% | 80 in 2030−9.1%/yr |
| Wisconsin | 3 | 135+14%/yr | +14%/yr | 0.2 | 100% | 140 in 2030+0.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 40 | 1,579−8.6%/yr | −8.6%/yr | 3.31.1× | 9% | 1,920 in 2030+3.3%/yr |
| Lumbar fusion | 38 | 1,451−4.5%/yr | −4.5%/yr | 3.11.1× | 2% | 1,850 in 2030+4.1%/yr |
| Cervical fusion & disc arthroplasty | 9 | 723−4.6%/yr | −4.6%/yr | 1.51.1× | 0% | 840 in 2030+2.4%/yr |
| Kyphoplasty & vertebroplasty | 1 | 310−5.8%/yr | −5.8%/yr | 0.70.5× | 8% | 290 in 2030−1.1%/yr |
SI joint fusion in every state, and its device makers · Every procedure market in Minnesota · Every state · Compare with Ohio
SI-BONE leads with 98% of company spending on these surgeons in 2025, level with 2024.
In 2025, 5 companies reported engagement with Minnesota’s surgeons worth $180K in consulting, speaking, meals and travel tied to these products, about $60K per surgeon billing it. Royalties are left out.
FDA, last 12 months: 7 clearances and approvals in the category, 1 recalled product line. A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.